AstraZeneca:  www.astrazeneca.com
I.D.:   A major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services.

Azaya Therapeutics:  www.azayatherapeutics.com
I.D.:  San Antonio’s innovative nanotherapy company working to improve the safety and efficacy of chemotherapy drugs.

BioMedical Enterprises (BME):  www.bme-tx.com
I.D.:  BME’s business initiatives as a medical device manufacturer and research service provider have allowed it to increase the medical community’s knowledge in osteoporosis, bone healing, and bone replacement materials. BME's strategy is focused on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response.

BioNumerik Pharmaceuticals, Inc.:  www.bionumerik.com
I.D.:  BioNumerik Pharmaceuticals, Inc. is focused on the discovery, development and commercialization of novel drugs for the treatment of cancer and cancer supportive care.  The company currently has two drug candidates, Karenitecin (BNP1350) and Tavocept, in late-stage clinical development.

Conceptual MindWorks, Inc.: www.conceptualmindworks.com
CMI, a woman-owned, small disadvantaged business, is a biotechnology and software engineering company with core competencies in biological research, bioinformatics, modeling, and simulation. CMI's commercial product is an Electronic Health Record called SevocityTM.

Dental Implant Technologies:  www.implanttechnologies.com
I.D.:  Dental Implant Technologies provides the most comprehensive suite of digitally integrated restorative services and products for full arch dental implant patients.

DPT Laboratories:  www.DPTLabs.com
I.D.:   A contract development and manufacturing organization (CDMO) offering full service sourcing solutions for the world’s leading pharmaceutical, biotechnology and healthcare companies.

Evestra:

Frio Pharmaceuticals: mccloskey@biodevcorp.com
Frio Pharmaceuticals is commercializing a portfolio of pharmaceuticals that decrease bacterial bioburden in the mouth, reduce chronic inflammation, and subsequently improve systemic health. Frio has two drugs in Phase 2 clinical trials.

Genzyme Oncology:  www.genzymeoncology.com
I.D.:  Genzyme Oncology is developing and commercializing novel treatments for cancer through internal research and active collaborations.  Marketed products are Campath® and Clolar®.

Humana Inc.: www.humana.com
I.D.: Humana Inc. is one of the nation’s largest publicly traded health benefits companies, with approximately 11.3 million medical members, including more than 500,000 in Texas. Humana offers a diversified portfolio of health insurance products and related services.

INCELL Corporation, LLC:  www.incell.com
I.D.:  INCELL will impact global health by changing the way vaccines are manufactured and delivered, and will provide innovative cell, tissue, and gene solutions to regenerative medicine.

Kinetic Concepts, Inc. (KCI):  www.kci1.com
I.D.:  KCI is a global medical technology company that designs and manufactures a wide range of proprietary products that can improve clinical outcomes and can help reduce the overall cost of patient care.

LIFETECHniques, Inc.: www.medsignals.com
Smart, communicating pillboxes alert at pill-times, monitor and report medication adherence, improve outcomes and lower utilization costs

www.smokesignals.net
Combines behavioral method and embedded technology to build personalized cessation plans, demonstrating higher quit rates at half the cost of drug solutions.

Mission Pharmacal: www.missionpharmacal.com
I.D.: For more than sixty years, privately held Mission Pharmacal has been dedicated to identifying unmet health needs and developing innovative products to meet them.

OncoVista, Inc.:  www.oncovista.com
I.D.:  Develops innovative, targeted therapies for cancer treatment which are safe, efficacious and capable of extending, and improving the quality of life for patients.

Pronucleotein Biotechnologies LLC:  www.otcorp.com/biotech/biotech.asp
I.D.:  An emerging leader innovating aptamer-based, hand-held diagnostic assay development that eliminates culture enrichment for real-time, rapid testing for food/water safety, homeland security.

Smith & Nephew Endoscopy:  www.endo.smith-nephew.com/US/Home.asp
I.D.:  A leader in developing Innovative Tissue Repair Solutions for sports medicine indications.  The TRUREPAIR product line provides porous structural, bioresorbable scaffolds uniquely designed for the repair and replacement of bone.

Volcano Corporation (CardioSpectra):